129 related articles for article (PubMed ID: 8384189)
1. [Comments on the contribution by M. Vogt et al. New developments and prospects in antiviral chemotherapy].
Rieckemann B; Ranneberg B
Internist (Berl); 1993 Feb; 34(2):190. PubMed ID: 8384189
[No Abstract] [Full Text] [Related]
2. [New developments and prospects of antiviral chemotherapy].
Vogt M; Bernasconi E; Lüthy R
Internist (Berl); 1992 Sep; 33(9):597-601. PubMed ID: 1328109
[No Abstract] [Full Text] [Related]
3. [Mechanisms of antiviral resistance among the herpesvirus group].
Reina J
Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408
[No Abstract] [Full Text] [Related]
4. Some aspects of the chemotherapy of herpes virus infections.
Cohen SS
Adv Pathobiol; 1976; (5):173-6. PubMed ID: 220854
[No Abstract] [Full Text] [Related]
5. Antiviral chemotherapy--a frontier for health and learning.
Jackson GG
Yale J Biol Med; 1982; 55(3-4):369-74. PubMed ID: 6295012
[TBL] [Abstract][Full Text] [Related]
6. Antiviral chemotherapy.
Eggers HJ
Infection; 1984; 12(5):313-4. PubMed ID: 6210252
[No Abstract] [Full Text] [Related]
7. [Viruses and antiviral drug resistance].
Hovi T; Järvinen A; Pyhälä R; Ristola M; Salminen M
Duodecim; 2002; 118(9):911-8. PubMed ID: 12238169
[No Abstract] [Full Text] [Related]
8. Antiherpesvirus drugs: a promising spectrum of new drugs and drug targets.
Coen DM; Schaffer PA
Nat Rev Drug Discov; 2003 Apr; 2(4):278-88. PubMed ID: 12669027
[TBL] [Abstract][Full Text] [Related]
9. [Use of new antiviral preparations, nuclease enzymes, in neuroviral infections].
Lobzin VS; Sichko ZhV
Voen Med Zh; 1973 Aug; (8):47-50. PubMed ID: 4375882
[No Abstract] [Full Text] [Related]
10. [Treatment of mucocutaneous herpes in 1988].
Rybojad M; Puissant A
Ann Med Interne (Paris); 1988; 139(7):499-503. PubMed ID: 2854379
[No Abstract] [Full Text] [Related]
11. Effective chemotherapy of equine herpesvirus 1 by phosphonylmethoxyalkyl derivatives of adenine demonstrated in a novel murine model for the disease.
Field HJ; Awan AR
Antimicrob Agents Chemother; 1990 May; 34(5):709-17. PubMed ID: 2163242
[TBL] [Abstract][Full Text] [Related]
12. [New approaches to the chemotherapy of herpesvirus infections].
Chizhov NP; Golovina GI; Iurlova TI; Briazzhikova TS
Antibiot Khimioter; 1993; 38(10-11):75-82. PubMed ID: 8085898
[No Abstract] [Full Text] [Related]
13. The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo.
Kaptein SJ; Efferth T; Leis M; Rechter S; Auerochs S; Kalmer M; Bruggeman CA; Vink C; Stamminger T; Marschall M
Antiviral Res; 2006 Feb; 69(2):60-9. PubMed ID: 16325931
[TBL] [Abstract][Full Text] [Related]
14. [The role of antiviral chemotherapy in dentistry].
Bourgeois G
Chir Dent Fr; 1970 Jan; 40(1):28-32. PubMed ID: 4311999
[No Abstract] [Full Text] [Related]
15. Research in the field of antiviral chemotherapy performed in the "Stefan S. Nicolau" Institute of Virology.
Eşanu V
Virologie; 1984; 35(4):281-93. PubMed ID: 6097022
[TBL] [Abstract][Full Text] [Related]
16. Latency and acquired resistance--problems in chemotherapy of herpes infections.
Darby G; Field HJ
Pharmacol Ther; 1983; 23(2):217-51. PubMed ID: 6322214
[No Abstract] [Full Text] [Related]
17. [Anti-herpes chemotherapy].
Ingrand D
Rev Prat; 1999 Dec; 49(20):2237-41. PubMed ID: 10731809
[TBL] [Abstract][Full Text] [Related]
18. Significant inhibitory effects of Hybridon's antisense compound on various HIV-1 replication steps in in vitro tests.
AIDS Patient Care STDS; 1996 Dec; 10(6):375-6. PubMed ID: 11361558
[No Abstract] [Full Text] [Related]
19. Editorial comment: antiviral chemotherapy.
Plotkin SA
J Pediatr; 1972 Mar; 80(3):493-5. PubMed ID: 4334179
[No Abstract] [Full Text] [Related]
20. [Early antiretroviral combination therapy--standard today and tomorrow].
Dtsch Med Wochenschr; 1997 Mar; 122(11 Suppl):1-4. PubMed ID: 9102288
[No Abstract] [Full Text] [Related]
[Next] [New Search]
